Nu Skin Enterprises, Inc. (NUS)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
Research Workspace
Put NUS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Household Products is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is contracting — down about 15% over the past year.
View GrowthManagement screens weak on capital allocation, earnings delivery, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 64% in its worst 12-month stretch.
View RiskNu Skin's growth relies on executing the Prysm iO rollout and launching in India. Revenue declined 17% year over year, but the latest guidance suggests a Q3 range of $310M-$340M. It trades at 5.0× P/E versus a peer median of 17.0×, indicating the price reflects less growth than forecasted. The miss probability for the next quarter is 26%. If guidance is cut after a recent raise, it could damage credibility. Peer multiples imply a price about 64% above where it trades. Our read remains intact.
Trailing returns as of 2026-09-04. NUS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare NUS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| NUS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Household Products — fair value, gap to price, and forward P/E.
Compare the value case
Put NUS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Execute Prysm iO rollout and India market launch
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Q3 revenue range supports Prysm iO rollout and device targets.

Advances: Q2 2026 revenue guidance
Q2 revenue guidance aligns with management's growth objectives.
Prysm iO device placement signals significant growth potential.
Launch of Prysm iO platform supports expansion strategy.